BioCentury
ARTICLE | Product Development

Moving Beyond a Buzzword: How small- to mid-sized biotechs can adopt patient centricity in oncology trials

Guest Commentary: Even small steps toward patient engagement can improve cancer trial recruitment, reduce costs

July 13, 2019 1:48 AM UTC


Access this Article